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Abstract
Intensification of process is increasingly interesting in the context of recovery of indus-
trial wastes. Among these compounds, animal blood is underexploited although it is an 
important source of bioactive peptides. LVV-h7 (LVVYPWTQRF) is one of these bioactive 
peptides from bovine haemoglobin hydrolysate. Our innovative approach consists of a 
continuous process involving at microfluidic scale for enzymatic proteolysis of bovine 
haemoglobin by pepsin, selective extraction of LVV-h7 to an organic solvent during the 
enzymatic reaction, followed by a second extraction to an aqueous phase for organic 
solvent recycling. Thus, the obtainment of pure LVV-h7 peptide with an efficient meth-
odology of extraction and solvent recycling was proved.
Keywords: haemoglobin, enzymatic hydrolysis, extraction, microfluidic, solvent 
recycling, bioactive peptides
1. Introduction
Intensification of process is considered as an indispensable part in the development of 
approach for obtaining product with high added value. The improvement of a process could 
concern the technology used, the safety or also the source of raw material employed. Among 
these sources, wastes of agricultural and food processing are considered as a cheap source of 
valuable components since the existent technologies allow the recovery of target compounds 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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and their recycling [1]. The process was developed at industrial scale to valorise these kinds 
of products [2]. In this work, animal blood was studied as a source of bioactive peptides [3–6]. 
Some of these peptides revealed their potential as antimicrobial [7], opioid [8], antihyperten-
sive [8] or antioxidative activities [9]. These peptides are generally obtained by enzymatic 
degradation of haemoglobin alpha and beta chains [3]. Among these peptides, one opioid 
peptide was studied, known as LVV-haemorphin-7. LVV-h7 corresponds to the amino acid 
sequence LVVYPWTQRF (Leu-Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg-Phe), obtained from β chain 
of haemoglobin (β 31–40) by pepsin hydrolysis and well known as bioactive peptides involved 
in the treatment of humans diseases [8, 10–12].
LVV-h7 presents also interesting physical properties, especially hydrophobic character which 
makes it able to transfer from aqueous to organic media in liquid/liquid extraction process 
[13]. Previous studies were interested to extract this peptide during haemoglobin hydrolysis 
using water/butan-2-ol-octan-1-ol liquid/liquid biphasic system [14–16]. Even if this process 
has shown the ability to extract selectively LVV-h7, its implementation was very complex 
and laborious, due to the long time of the process carried out (more than 10 h) to obtain low 
extraction yield of peptide (about 5%), the control of the immobilised enzyme stability during 
the process to avoid its inhibition by solvents and a high quantity of solvent.
Keeping in mind the economic and environmental impacts of a process development which 
requires the use of organic solvent, the microfluidic domain could bring solutions to reduce 
these disadvantages. First, reduction of scale allows to improve the surface/volume ratio and 
thus the molecular transfer capacity while reducing the volume of solvent used and energy 
[17, 18]. Second, the implementation for continuous flow platforms brings advantages of 
liquid-liquid transfer favoured by laminar flow [19–21], in the case of non-miscible liquids, for 
molecular transfer. Several studies revealed the real advantage of using LLE in microfluidic 
system [19, 22–23].
Previous study realised on the enzymatic hydrolysis of haemoglobin by pepsin in a microflu-
idic reactor has shown the influence of the microfluidic scale to the kinetics acceleration of bio-
active peptides appearance, such as LVV-h7, comparing to bench scale [24]. This study shows 
also the potential of combining enzymatic microreactor with liquid/liquid biphasic system for 
LVV-h7 extraction. Therefore, the approach that we propose is based on continuous aqueous 
haemoglobin hydrolysis by pepsin, LVV-h7 extraction towards an intermediate organic phase 
and LVV-h7 DES extraction in a receiving aqueous phase, allowing the solvent recycling. This 
integrated process with solvent recycling is presented in Figure 1. Before fully designing the 
entire microfluidic process, where all the reactions are carried out simultaneously, we separately 
investigated each reaction to notably determine their respective optimal ranges of conditions 
before combination as follows: (1) haemoglobin hydrolysis by pepsin occurs in a primary aque-
ous feed phase, generating the LVV-h7 in a very complex peptide mixture with more than one 
hundreds of peptides with different primary sequences; (2) the as-formed LVV-h7 is then selec-
tively extracted into an organic solvent (octan-1-ol); (3) eventually, the LVV-h7 is des extracted 
in a second aqueous phase (called receiving aqueous phase), which also allows the octan-1-ol 
recycling in the extraction step. Our approach is not only focused on the compatibility issues of 
enzymatic catalysis and opioid peptide extraction, but also pays particular attention to integrat-
ing all the steps to minimise separation and recycling burdens, which can be detrimental for the 
overall economics and efficiency of the process. The methodology envisioned to move from a 
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sequential approach towards an integrated continuous process is schematised in Figure 2. Each 
step was optimised to obtain the best conditions concerning LVV-h7 concentration and purity, 
through residence time (i.e. flow rate) of both aqueous and organic phases inside the system. 
Figure 1. Simultaneous process applied to the haemoglobin hydrolysis by pepsin, the liquid/liquid extraction of LVV-h7 
and the solvent recycling, to produce pure opioid peptide.
Figure 2. Methodology from a sequential approach towards an integrated continuous process.
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After optimisation, enzymatic hydrolysis and extractions steps were combined for a continuous 
approach to obtain final aqueous phase containing the bioactive peptide. Quantification and 
purity of LVV-h7 were determined to evaluate the efficiency of integrated process.
2. Experimental procedure
2.1. Haemoglobin hydrolysis by pepsin
Bovine haemoglobin (64.5 kDa, Sigma Chemicals Co.) was hydrolysed by porcine pepsin (E.C. 
3.4.23.1, 3.440 U mg−1, 35 kDa, Sigma Chemicals Co.), protease from the family of aspartic acid 
proteases which preferentially catalyses the cleavage of peptide bonds at the carboxyl side of 
aromatic and hydrophobic amino acids. This proteolytic reaction leads to the appearance of 
product molecules called peptides. Haemoglobin was prepared under denaturing conditions 
at pH 3.0 by adding 2 M HCl for a 20 mg mL−1 final concentration. All aqueous solutions were 
prepared in 18.2 MΩ Milli-Q water (Millipore).
In order to obtain a maximum concentration of LVV-h7 peptides for the extraction step stud-
ies, kinetic of reaction was implemented in microfluidic system (75 μm inner diameter, 2 m 
length). Denatured bovine haemoglobin (1% w/v) was hydrolysed by porcine pepsin at differ-
ent flow rates (9, 4.5, 1, 0.4 and 0.2 μL min−1), which corresponded to a residence time of 15 s, 
30 s, 2 min, 5 min and 10 min, respectively. Samples of peptidic solution were collected during 
the reaction and mixed with sodium hydroxide 1 M in order to inhibit the pepsin. Samples 
were conserved at 4°C for RP-HPLC analysis to determine the progress of the reaction.
2.2. Extraction of LVV-h7 from feed aqueous phase containing peptidic hydrolysate 
to octan-1-ol phase
Previous studies have shown the choice of octan-1-ol as the better extraction solvent for hydro-
phobic peptides and particularly in the case of LVV-h7 [16, 25]. The haemoglobin hydrolysate 
was pumped using peristaltic pump (Minipulls 3, Gilson Inc., Middleton, WI, USA) and sent 
in co-flow with octan-1-ol solution in the same capillary (75 μm inner diameter, 10 cm length) 
for liquid-liquid extraction (LLE) of peptides from haemoglobin phase to the organic phase. 
The liquid-liquid extraction was performed with different flow rates to appreciate the impact 
of contact time on the opioid peptide extraction. The two phases were collected out of the 
capillary in a 2 mL Eppendorf, immediately separated and analysed by RP-HPLC.
2.3. DES extraction of LVV-h7 from organic phase to receiving aqueous phase
Octan-1-ol phase obtained after the extraction procedure was pumped with peristaltic pump 
and fed in another capillary where acidic water (pH 3 obtained with acetic acid adjustment) was 
injected at different flow rates to perform a second liquid-liquid extraction from the octan-1-ol 
to the aqueous phase, called “DES extraction step”. In these conditions, the acidic water extracts 
peptides and favours the extraction without mixing of the two phases [26]. Phases were collected 
out of the capillary in a 2 mL Eppendorf, immediately separated and analysed by RP-HPLC.
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2.4. Coupling of extraction and DES extraction procedure
A coupling between both extractions optimised method was implemented, and its efficiency 
on LVV-h7 peptide extraction selectivity was measured. The entire system was represented 
on scheme Figure 3 where the volume containing the peptidic hydrolysate and the octan-1-ol 
was pumped in the same capillary for extraction, followed by a pumping of octan-1-ol phase 
recovered in a second capillary, connected with acidic water for DES extraction of LVV-h7. For 
each part of the process, samples were collected for identification and quantification of species.
2.5. Reversed-phase-HPLC analysis
The liquid chromatographic system is consisted of a Waters 600E automated gradient control-
ler pump module, a Waters Wisp 717 automatic sampling device and a Waters 996 photo-
diode array detector. Spectral and chromatographic data were stored in a NECImage 466 
computer. Detection of the produced peptides was carried out at 215 nm by reverse phase 
HPLC (RP-HPLC) on a C4-column (Vydak 0.46 × 25 cm, 3 mm I.D.). The mobile phase was 
water/trifluoroacetic acid (100, 0.1, v/v) and acetonitrile/water/trifluoroacetic acid (60, 40, 0.1, 
by vol.) at 0.4 mL min−1 flow rate. All common chemicals and reagents were of analytical 
grade and were purchased from Sigma Chemicals Co. and Flandres Chimie. Identification 
and quantification of LVV-h7 were performed using peptide standard (purity: 91.63% M.W. 
1308.56 Da) purchased from GeneCust Society (Luxembourg).
2.6. MALDI-TOF mass spectrometry analysis
The sample was loaded on a ground steel MALDI target (Bruker Daltonics, Bremen, Germany) 
following the dried droplet method. The MS (positive reflectron mode) and MS/MS (lift 
mode) measurements were performed in an automatic mode on an AUTOFLEXTM Speed 
Figure 3. Implementation of microfluidic extraction and DES extraction steps of LVV-h7 from hydrolysate and recycling 
phases (black: employed method for extraction; green: recycling possibilities of solution).
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TOF/TOF mass spectrometer (Bruker Daltonics) running FlexControlTM3.0 software (Bruker 
Daltonics). Peptide fragmentation was performed by automatic method of the manufacturer. 
MS and MS/MS spectra were processed using FlexanalysisTM3.3 and BioTools 3.4 software 
packages (Bruker Daltonics). Fragmentation pattern of peptides was deduced from match-
ing of amino acid sequences (Uniprot accession numbers: P02070 & P01966) of each chain of 
bovine haemoglobin to the MS/MS spectra using BioTools 3.4.
3. Results and discussion
3.1. Haemoglobin hydrolysis by pepsin in feed aqueous phase
Haemoglobin 1% (w/v) was hydrolysed by porcine pepsin at room temperature, at pH 3 
and at different residence time of substrate and enzyme in the microchannel. At the outlet of 
the capillary, samples were sent to an Eppendorf containing a disodium tetraborate buffer 
solution (0.32 M, pH 9.0), that caused enzyme denaturation and thus reaction stopping, and 
analysed by RP-HPLC.
Figure 4 shows the progressive decrease of alpha and beta chains of haemoglobin (between 40 
and 60 min) to generate intermediate peptides (between 25 and 40 min) after 15 s of reaction. 
Next, after 30 s of reaction, there is an increase of peptide population between 25 and 30 min 
and an emergence of peptides between 15 and 25 min. For the last samples (5 and 10 min), 
there is a disappearance of peptides between 30 and 40 min to the profit of peptides between 
5 and 25 min. This phenomenon was already described in the literature and was explained 
by an enzymatic hydrolysis of alpha and beta chains to produce a population of hydrophobic 
peptides with high molecular weight, observed between 30 and 35 min in Figure 3 [3, 5]. 
Next, this population is hydrolysed to produce other peptides with intermediate molecular 
weight, observed between 20 and 30 min. Finally, these intermediate peptides are hydrolysed 
to generate small peptides with hydrophilic character (retention time between 5 and 20 min). 
This mechanism is called “zipper” mechanism, which is characterised by a denatured state 
of the initial haemoglobin structure. Moreover, this mechanism is more suitable for obtaining 
intermediate bioactive peptides, such as LVV-h7 (retention time of about 29 min in Figure 4), 
compared to a “one by one” mechanism where initial haemoglobin structure is in a native 
state [3, 5]. LVV-h7 was used as a standard to evaluate the efficiency of extraction process by 
octan-1-ol. Thus, for studying of the extraction step in microfluidic system, we decided to stop 
the reaction after 30 s of hydrolysis by sodium hydroxide 1 M in order to obtain the maximum 
quantity of LVV-h7 (Figure 3c).
3.2. Study of LVV-h7 extraction in octan-1-ol using microfluidic system
Haemoglobin hydrolysate whose concentration of LVV-h7 was the more important (1%, 30 s 
of hydrolysis with pepsin) was injected in co-flow (using a T connector) with octan-1-ol at 
different flow rates (5, 10, 20 and 50 μL min−1). Samples were collected in Eppendorf, and 
octan-1-ol phase was analysed by RP-HPLC to highlight the extracted peptides. Results are 
shown in Figure 5.
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The flow rates used for our analysis correspond to the additive flow rates of both solutions 
during the extraction step (i.e. initial flow rate multiplied by 2). Chromatograms show a 
good selectivity of the LLE method and octan-1-ol using microfluidic system. Indeed, we 
observe only three major peaks from the initial complex peptidic hydrolysate. Moreover, a 
predominance of LVV-h7 peptide is observed (RT of 29 min), which represents more than 
55% of the peptides extracted by octan-1-ol. The selectivity of octan-1-ol for hydrophobic 
Figure 4. RP-HPLC chromatograms of haemoglobin 1% hydrolysed by porcine pepsin for different residence times of 
both haemoglobin and pepsin solutions. (a) Denatured haemoglobin without enzyme, (b) 15 s, (c) 30 s, (d) 2 min, (e) 
5 min and (f) 10 min. Samples were analysed on C4 column.
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peptides such as LVV-h7 was previously confirmed by our team in batch and continuous 
reactors from enzymatic haemoglobin hydrolysates, but not in microfluidic system [14–16]. 
Two other peaks (RT of 27 and 31 min) are observed and supposed having a hydrophobic 
character.
The three peaks identified in the octan-1-ol phase were analysed by MALDI mass spectros-
copy to appreciate their composition (Figure 6).
Concerning the fraction eluted at a 29 min (Figure 6b), result from mass spectroscopy shows 
unique peak at m/z = 1308.930 Da corresponding to molecular weight for LVV-h7 (with one 
hydrogen more from mass analysis). No other components were observed, which shows that 
LVV-h7 peptide is pure. The other fractions collected were also identified. At retention time 
Figure 5. HPLC chromatograms of octan-1-ol phase after extraction applied on haemoglobin hydrolysate in microfluidic 
system at different flow rates ((a) 10 μL min−1, (b) 20 μL min−1, (c) 40 μL min−1 and (d) 100 μL min−1).
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of 27 min, another pure peptide with 1195.933 Da for molecular weight was identified. It 
corresponds to the VV-h7 peptide, also obtained by haemoglobin hydrolysis with pepsin 
and characterised as a hydrophobic bioactive peptide [7]. The fraction eluted at 31 min was 
composed of two major compounds (1422.138 and 1733.23 Da). These peptides correspond to 
other peptides without known biological activity.
Finally, using standard concentration curve (R2 = 0.98) prepared with a pure standard of 
LVV-h7 (GeneCust, 91%), the quantity of pure LVV-h7 extracted from bovine haemoglobin 
hydrolysate was 6.12 ± 0.34 μg mL−1. With an initial concentration of LVV-h7 calculated at 
16.12 ± 0.85 μg mL−1 in the hydrolysate, performance of our system is around 38% of peptide 
extracted with only one cycle of extraction.
Table 1 resumes the total area of peptides extracted and particularly for LVV-h7 depending 
on the flow rate and thus on the residence time of hydrolysate in the microsystem. The area of 
peptides extracted from peptidic hydrolysate increases with the decreasing of flow rate used, 
confirming the influence of the time of contact between both phases in the capillary. A relative 
high time of contact between peptidic hydrolysate and octan-1-ol favours the diffusion of 
peptides to the solvent phase. However, even if the quantity of LVV-h7 obtained between 10 
Figure 6. MALDI-TOF spectra obtained for each peak (elution time (a) 27 min, (b) 29 min and (c) 31 min) collected after 
octan-1-ol extraction and separated by RP-HPLC.
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and 20 μL min−1 was relatively proportional (×1.5), this difference was less marked for flow 
rates used up to 20 μL min−1.
3.3. Study of LVV-h7 DES extraction from octan-1-ol to receiving aqueous phase
Using the same process than in the first extraction (from peptidic hydrolysate to octan-1-ol), 
the octan-1-ol phase containing peptides was injected in co-flow with acidic aqueous phase 
in order to transfer these peptides from organic to receiving aqueous phase. Different flow 
rates were used to evaluate the impact of contact time between the two phases during the DES 
extraction process.
Chromatograms (Figure 7) show clearly a transfer of peptides from the organic phase to the 
aqueous phase by liquid-liquid DES extraction in the microfluidic conditions. The three major 
fractions corresponding to the peptides previously described and mainly present in the initial 
octan-1-ol phase were found in the receiving aqueous phase. Moreover, a small proportion of 
these peptides were still present in octan-1-ol after the DES extraction step. Figure 8 illustrates 
the concentration of LVV-h7 in octan-1-ol and the receiving aqueous phase after the DES 
extraction for different flow rates.
The LVV-h7 concentration in the aqueous phase increases with the decrease of flow rate, 
indicating the influence of contact time between the two phases on the peptide diffusion. 
For 10 μL min−1, more than 82% of the initial concentration of LVV-h7 phase was trans-
ferred in the aqueous phase. The calculation of LVV-h7 proportion in the aqueous phase 
compared to the total quantity of peptides extracted was 50 ± 1%. LVV-h7 fraction was 
analysed by MALDI mass spectroscopy to verify its purity (result not shown). Mass analy-
sis reveals the purity of the LVV-h7 fraction to recover from organic phase to the receiving 
aqueous phase using microfluidic system. Both fractions (27 and 31 min) were also anal-
ysed by mass spectroscopy. It confirmed the same composition than obtained during the 
extraction step that is, a pure VV-h7 peptide for 27 min of elution time and other peptides 
for 31 min. Thus, the DES extraction step of peptides from octan-1-ol phase to an acidic 
aqueous phase using microfluidic system was validated with a good efficiency (more than 
82% of transfer yield).
Flow rate (μL 
min−1)
Time of contact 
(s)
Total area of peptides 
(μV/*s)
LVV-h7 area (μV/*s) Total % of LVV-h71
10 2.65 10,793,556 6,292,478 58
20 1.32 6,976,911 4,064,156 58
40 0.66 6,316,966 3,599,507 57
100 0.26 5,921,488 3,181,856 54
1Total % LVV-h7 = (area of LVV-h7/total area) × 100)
Table 1. Proportion of LVV-h7 in total area of peptides after extraction process.
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3.4. Simultaneous haemoglobin hydrolysis by pepsin in feed aqueous phase,  
LVV-h7 extraction in octan-1-ol and DES extraction in receiving aqueous phase
In the optimal conditions previously determined, a continuous integrated process was tested. 
The microfluidic system, phases and matter flows are presented in Figure 1. The experiment 
was conducted following the same approach than those in Figure 3 but with a feed aqueous 
phase formed by a haemoglobin solution, previously prepared under denaturing conditions at 
pH 3.0 (see part 3.1, haemoglobin final concentration of 1%, p/v), and a solution of pepsin with 
a E/S ratio of 1/11 (mol/mol). The introduction of these solutions in the microreactor (75 μm I.D. 
× 150 μm O.D.) was achieved by a syringe pump with a flow rate for both pepsin and haemoglo-
bin solutions at about 4.5 μL min−1 for a capillary length of 2 m. The flow rates used correspond 
to the additive flow rates of both solutions, that is, initial flow rate multiplied by 2. The outlet 
fused silica capillary was in contact with a disodium tetraborate buffer solution (0.32 M, pH 9.0), 
thanks to a T-connection and a capillary (75 μm inner diameter, 10 cm length, flow rate of 
5 μL min−1), that caused enzyme denaturation and thus reaction stopping. Consequently to the 
enzymatic reaction, the resulting peptidic hydrolysate was sent in co-flow in a T-connector with 
Figure 7. RP-HPLC chromatograms of octan-1-ol phase before DES extraction of peptides (a) water phase, (b) and octan-
1-ol phase (c) obtained after DES extraction in microfluidic system for a flow rate of 20 μL min−1.
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octan-1-ol solution in a new capillary (75 μm inner diameter, 10 cm length) for LVV-h7 extraction 
at 10 μL min−1. The two phases were collected out of the capillary in an Eppendorf. Octan-1-ol 
was pumped at 10 μL min−1 in a third capillary connected with acidic water for DES extraction 
of LVV-h7 thanks to a T-connector. Finally, the octan-1-ol phase remaining was pumped (10 μL 
min−1) and re-injected in the initial octan-1-ol phase for a new cycle of extraction-DES extraction. 
To avoid the pumping of the bad phase, an offset of 10 min was done between each extraction 
step to have sufficient volume of phases. For each step of the continuous process, samples were 
collected for identification and quantification of species (Figure 9 and Table 2).
First, the peptidic profile obtained during the enzymatic hydrolysis step confirms the results 
previously obtained by Elagli et al. [24] and the presence of LVV-h7 in the reaction medium 
(Figure 9a). Then, extraction of the opioid peptide to octan-1-ol phase is also observed in 
Figure 9b, showing the good selectivity of the organic phase for the same hydrophobic pep-
tides detected before, whose LVV-h7 (Figure 7). Finally, we observe the haemorphin in the 
acidic receiving aqueous phase, confirming the DES extraction step efficiency. A proportion 
of the peptidic fractions is also found in the octan-1-ol phase after the DES extraction, trans-
lating an incomplete transfer in the receiving aqueous phase. However, results validate the 
process of simultaneous enzymatic hydrolysis of haemoglobin with LVV-h7 extraction and 
DES extraction at the microscale level.
The calculation of the different concentrations of LVV-h7 in each phase (Table 2) shows the trans-
fer of 78% of the initial concentration of LVV-h7 from octan-1-ol to water. This result confirms 
the efficiency of the coupling approach of the extraction-DES extraction steps in microfluidic 
system after the enzymatic reaction. Moreover, after the DES extraction step, a low concentra-
tion of LVV-h7 remained in octan-1-ol phase (1.64 μg mL−1). Thus, the reuse of octan-1-ol for a 
new cycle of extraction allows to obtain an efficient method of peptide recovery with a minimal 
of organic solvent quantity. An optimisation of the process, particularly the time of contact 
Figure 8. Proportion of LVV-h7 (μg mL−1) in each phase after the DES extraction step in the microfluidic system for 
different flow rates.
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between feed aqueous/organic phases during the extraction and receiving aqueous/organic 
phases during the DES extraction could certainly improve the final concentration of LVV-h7 
recovered and consequently decrease peptide concentration remained in the organic phase.
Figure 9. RP-HPLC chromatograms obtained from each step of the continuous process in the microfluidic system. (a) 
Peptidic hydrolysate after 30 s of haemoglobin hydrolysis by pepsin, (b) octan-1-ol phase after the extraction, (c) water 
phase after the DES extraction and (d) octan-1-ol phase after the DES extraction.




In this work, we have first provided the conditions of the key parameters in microfluidic 
systems (residence times, flow rates, and concentrations) applied for a sequential process 
from liquid/liquid extraction of LVV-h7, present in a very complex peptidic hydrolysate, 
in octan-1-ol to its DES extraction in a second acidic aqueous phase. The optimised condi-
tions have been then applied to an unprecedented integrated process in a specifically micro-
fluidic approach. Therein, enzymatic hydrolysis of denatured haemoglobin by pepsin in a 
first microfluidic system was coupled with LVV-h7 extraction in octan-1-ol. This organic 
phase was then put in contact with a second aqueous phase for LVV-h7 DES extraction. 
The microfluidic scale allowed to increase the ratio surface/volume in order to favour the 
transfer of hydrophobic peptide to the organic solvent. A very good selectivity of extraction 
of the opioid peptide is obtained, from a very complex peptidic population generated during 
the enzymatic hydrolysis of haemoglobin by pepsin, with more than 38% of LVV-h7 initial 
concentration transferred to the organic phase. The DES extraction reveals also a very good 
transfer of LVV-h7 from octan-1-ol to the acidic aqueous phase, with more than 80%. Thus, 
the simultaneous process allowed to recover until more than 6 μg mL−1 of LVV-h7 with an 
excellent purity measured by mass spectroscopy with only one cycle of process (2.65 s of 
contact for each LLE).
The coupling of both extractions confirmed the feasibility of this process with a recycling of 
each phase to obtain a continuous process of extraction at microfluidic scale. An optimisation 
of the time of contact during the extraction is the key of peptide transfer between each phase 
and particularly for the recycling step. Currently, a study of a complete continuous process is 
in progress, where pepsin is immobilised in the microchannel and the outlet microcapillary 
is directly in contact with a solution of octan-1-ol, to avoid stopping the enzymatic reaction 
before extraction.
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Phases collected LVV-h7 area (μV/*s) LVV-h7 concentration (μg mL−1)
Octan-1-ol (extraction step) 6,354,896 6.18
Octan-1-ol (DES extraction step) 1,687,646 1.64
Water (DES extraction step) 4,982,647 4.85
Table 2. Concentrations of LVV-h7 in each phase during the complete process.
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